A Single Nucleotide Variant in the FMR1 CGG Repeat Results in a “Pseudodeletion” and Is Not Associated with the Fragile X Syndrome Phenotype  Massimiliano.

Slides:



Advertisements
Similar presentations
Measurement of Relative Copy Number of CDKN2A/ARF and CDKN2B in Bladder Cancer by Real-Time Quantitative PCR and Multiplex Ligation-Dependent Probe Amplification.
Advertisements

An Enhanced Polymerase Chain Reaction Assay to Detect Pre- and Full Mutation Alleles of the Fragile X Mental Retardation 1 Gene  Alessandro Saluto, Alessandro.
Detection of Exon 12 Mutations in the JAK2 Gene
Diagnostic Testing for Rett Syndrome by DHPLC and Direct Sequencing Analysis of the MECP2 Gene: Identification of Several Novel Mutations and Polymorphisms 
Laila C. Schenkel, Charles Schwartz, Cindy Skinner, David I
A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X (FMR1) Gene in Newborn and High-Risk.
Screening for Mutations in Kidney-Related Genes Using SURVEYOR Nuclease for Cleavage at Heteroduplex Mismatches  Konstantinos Voskarides, Constantinos.
DNA-based prenatal exclusion of harlequin ichthyosis
A Pseudo-Full Mutation Identified in Fragile X Assay Reveals a Novel Base Change Abolishing an EcoRI Restriction Site  Shujian Liang, Harold N. Bass,
Expansion of an FMR1 Grey-Zone Allele to a Full Mutation in Two Generations  Isabel Fernandez-Carvajal, Blanca Lopez Posadas, Ruiqin Pan, Christopher Raske,
Isothermal Multiple Displacement Amplification
Betaine, Dimethyl Sulfoxide, and 7-Deaza-dGTP, a Powerful Mixture for Amplification of GC-Rich DNA Sequences  Marco Musso, Renata Bocciardi, Sara Parodi,
Yanggu Shi, Sharon F. Terry, Patrick F. Terry, Lionel G
Methylation-Specific Multiplex Ligation-Dependent Probe Amplification Enables a Rapid and Reliable Distinction between Male FMR1 Premutation and Full-Mutation.
Simultaneous Detection and Quantification of Mitochondrial DNA Deletion(s), Depletion, and Over-Replication in Patients with Mitochondrial Disease  Ren-Kui.
Performance Evaluation of Two Methods Using Commercially Available Reagents for PCR-Based Detection of FMR1 Mutation  Jane S. Juusola, Paula Anderson,
Hou-Sung Jung, Gregory J. Tsongalis, Joel A. Lefferts 
Molecular Typing of West Nile Virus, Dengue, and St
Fragile X Syndrome The Journal of Molecular Diagnostics
Jennifer Kerkhof, Laila C
Thomas W. Prior, Scott J. Bridgeman 
Detection of an Apparent Homozygous 3120G>A Cystic Fibrosis Mutation on a Routine Carrier Screen  Denise LaMarche Heaney, Patrick Flume, Lauren Hamilton,
William L. Gerald, M.D., Ph.D, 1954–2008
An Enhanced Polymerase Chain Reaction Assay to Detect Pre- and Full Mutation Alleles of the Fragile X Mental Retardation 1 Gene  Alessandro Saluto, Alessandro.
Reliable and Sensitive Detection of Fragile X (Expanded) Alleles in Clinical Prenatal DNA Samples with a Fast Turnaround Time  Sara Seneca, Willy Lissens,
Pathogenicity Evaluation of BRCA1 and BRCA2 Unclassified Variants Identified in Portuguese Breast/Ovarian Cancer Families  Catarina Santos, Ana Peixoto,
Detection of Exon 12 Mutations in the JAK2 Gene
A Novel Syndrome Combining Thyroid and Neurological Abnormalities Is Associated with Mutations in a Monocarboxylate Transporter Gene  Alexandra M. Dumitrescu,
Heteroduplex Formation in SMN Gene Dosage Analysis
Screening for Expanded Alleles of the FMR1 Gene in Blood Spots from Newborn Males in a Spanish Population  Isabel Fernandez-Carvajal, Paulina Walichiewicz,
A 39-bp Deletion Polymorphism in PTEN in African American Individuals
An Information-Rich CGG Repeat Primed PCR That Detects the Full Range of Fragile X Expanded Alleles and Minimizes the Need for Southern Blot Analysis 
Analysis of Rare APC Variants at the mRNA Level
BRAF Mutation Testing in Solid Tumors
A Synonymous Mutation in the CFTR Gene Causes Aberrant Splicing in an Italian Patient Affected by a Mild Form of Cystic Fibrosis  Valeria Faa′, Alessandra.
Comprehensive Mutation Analysis of the CYP21A2 Gene
A Highly Sensitive Genetic Protocol to Detect NF1 Mutations
Survival of Male Patients with Incontinentia Pigmenti Carrying a Lethal Mutation Can Be Explained by Somatic Mosaicism or Klinefelter Syndrome    The.
Comprehensive Arrayed Primer Extension Array for the Detection of 59 Sequence Variants in 15 Conditions Prevalent Among the (Ashkenazi) Jewish Population 
Syed Hussain Askree, Lawrence N
Rare Sequence Variation in the Genome Flanking a Short Tandem Repeat Locus Can Lead to a Question of “Nonmaternity”  Anne Deucher, Tsoyu Chiang, Iris.
A Simple Method to Confirm and Size Deletion, Duplication, and Insertion Mutations Detected by Sequence Analysis  Lawrence N. Hjelm, Ephrem L.H. Chin,
Julie Di Cristofaro, Monique Silvy, Jacques Chiaroni, Pascal Bailly 
A Simple, High-Throughput Assay for Fragile X Expanded Alleles Using Triple Repeat Primed PCR and Capillary Electrophoresis  Elaine Lyon, Thomas Laver,
Characterization of Aberrant Melting Peaks in Unlabeled Probe Assays
Detection of the JAK2 V617F Mutation by LightCycler PCR and Probe Dissociation Analysis  Marla Lay, Rajan Mariappan, Jason Gotlib, Lisa Dietz, Siby Sebastian,
A Novel Long-Range PCR Sequencing Method for Genetic Analysis of the Entire PKD1 Gene  Ying-Cai Tan, Alber Michaeel, Jon Blumenfeld, Stephanie Donahue,
A Novel Methylation PCR that Offers Standardized Determination of FMR1 Methylation and CGG Repeat Length without Southern Blot Analysis  Marina Grasso,
Rapid and Sensitive Real-Time Polymerase Chain Reaction Method for Detection and Quantification of 3243A>G Mitochondrial Point Mutation  Rinki Singh,
Deletion of the Cytoplasmatic Domain of BP180/Collagen XVII Causes a Phenotype with Predominant Features of Epidermolysis Bullosa Simplex  Marcel Huber,
A Novel Point Mutation Affecting the Tyrosine Kinase Domain of the TRKA Gene in a Family with Congenital Insensitivity to Pain with Anhidrosis  Shinichi.
An Allele-Specific RT-PCR Assay to Detect Type A Mutation of the Nucleophosmin-1 Gene in Acute Myeloid Leukemia  Tiziana Ottone, Emanuele Ammatuna, Serena.
Novel Polymorphism in the FMR1 Gene Resulting in a “Pseudodeletion” of FMR1 in a Commonly Used Fragile X Assay  Thomas M. Daly, Arash Rafii, Rick A. Martin,
Multiplex PCR Detection of GSTM1, GSTT1, and GSTP1 Gene Variants
Feras M. Hantash, Arlene Rebuyon, Mei Peng, Joy B
A Real-Time PCR Assay for the Simultaneous Detection of Functional N284I and L412F Polymorphisms in the Human Toll-Like Receptor 3 Gene  Robert A. Brown,
Demethylation, Reactivation, and Destabilization of Human Fragile X Full-Mutation Alleles in Mouse Embryocarcinoma Cells  Doris Wöhrle, Ulrike Salat,
Rapid Polymerase Chain Reaction-Based Detection of Epidermal Growth Factor Receptor Gene Mutations in Lung Adenocarcinomas  Qiulu Pan, William Pao, Marc.
Relationship between CFTR and CTRC Variants and the Clinical Phenotype in Late- Onset Cystic Fibrosis Disease with Chronic Pancreatitis  Anna C. Tomaiuolo,
Triplet Repeat Primed PCR (TP PCR) in Molecular Diagnostic Testing for Friedreich Ataxia  Paola Ciotti, Emilio Di Maria, Emilia Bellone, Franco Ajmar,
Rapid Allelic Discrimination by TaqMan PCR for the Detection of the Gilbert's Syndrome Marker UGT1A1*28  Ursula Ehmer, Tim O. Lankisch, Thomas J. Erichsen,
Karen Snow-Bailey, Ph.D., 1961–2006
Sensitive Detection of Polyalanine Expansions in PHOX2B by Polymerase Chain Reaction Using Bisulfite-Converted DNA  Hidekazu Horiuchi, Ayako Sasaki, Motoki.
Gabriella Esposito, Giuseppe Rescigno, Francesco Salvatore 
Analytical Evaluation of Primer Engineered Multiplex Polymerase Chain Reaction– Restriction Fragment Length Polymorphism for Detection of Factor V Leiden.
Extra Alleles in FMR1 Triple-Primed PCR
Xiangfeng Cui, Helen Feiner, Honghua Li 
Is Screening of the Candidate Gene Necessary in Unrelated Partners of Members of Families with Herlitz Junctional Epidermolysis Bullosa?  Alfred Klausegger,
Monique A. Johnson, Marvin J. Yoshitomi, C. Sue Richards 
Identification of Cystic Fibrosis Variants by Polymerase Chain Reaction/Oligonucleotide Ligation Assay  Karen M. Schwartz, Lisa L. Pike-Buchanan, Kasinathan.
Presentation transcript:

A Single Nucleotide Variant in the FMR1 CGG Repeat Results in a “Pseudodeletion” and Is Not Associated with the Fragile X Syndrome Phenotype  Massimiliano Cecconi, Francesca Forzano, Rosanna Rinaldi, Sandra Cappellacci, Paola Grammatico, Francesca Faravelli, Franca Dagna Bricarelli, Emilio Di Maria, Marina Grasso  The Journal of Molecular Diagnostics  Volume 10, Issue 3, Pages 272-275 (May 2008) DOI: 10.2353/jmoldx.2008.070163 Copyright © 2008 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 1 A: Southern blot analysis. DNA was double-digested with EcoRI and EagI and then probed with StB12.3. Family individuals were denoted as proband (P), proband's father (F), and proband's son (S). Proband shows the expected 2.8- and 5.2-kb bands and an extra band of 2.5 kb. The profile is compared to a normal female control (NF). The 2.8- and 2.5-kb bands show the same signal intensity, accounting for a random X inactivation. A premutated female (PF) showing a faint 2.9-kb premutation band attributable to a skewed X inactivation was presented as control. Both proband's father and son demonstrate loss of the normal 2.8-kb band and the appearance of a 2.5-kb smaller band. No expanded bands were detected in the family members. Images were taken from two experiments. B: Sequence analysis. The electropherograms show the heterozygous G>C substitution in the proband and the variant C allele in her father and son. The nucleotide substitution is marked by arrows. The EagI site introduced by the G>C substitution is underlined. C: The agarose gel shows the EagI-digested PCR products encompassing the GGC repeat. The proband shows three bands, one corresponding to the undigested normal allele (338 bp, detected in a normal female control) and two corresponding to the variant allele (EagI digestion products: 198 bp and 140 bp). The digested products were detected in both male hemizygous carriers of the pseudodeletion, the proband's son and the proband's father. The Journal of Molecular Diagnostics 2008 10, 272-275DOI: (10.2353/jmoldx.2008.070163) Copyright © 2008 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions